// App-Quantinova.ai

SAT0328 : OUTCOME OF INTERSTITIAL LUNG DISEASE (ILD) IN ANTI-PM/SCL PATIENTS WITH SYSTEMIC SCLEROSIS: RESULTS FROM AN EUSTAR CASE-CONTROL STUDY.

Researchers

Presenter

  • M. G. Lazzaroni

Principal Investigators

  • C. Campochiaro

  • E. Marasco

  • J. De Vries-Bouwstra

  • F. Franceschini

  • F. Del Galdo

  • C. Denton

  • L. Cavagna

  • O. Distler

  • Y. Allanore

  • P. Air

Medical Centers

  • Spedali Civili, University of Brescia, Brescia, Italy

  • San Raffaele Scientific Institute, Milan, Italy

  • Royal Free and University College Hospital Medical School, London, United Kingdom

  • Hospital IRCCS Policlinico S. Matteo Foundation of Pavia, University of Pavia, Pavia, Italy

  • Leiden University Medical Centre, Leiden, Netherlands

  • University Paris Descartes and Cochin Hospital, Paris, France

Locations

  • Italy

  • United Kingdom

  • Netherlands

  • Switzerland

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GSK plc

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved